drugset / Trial / NCT00133770
Intravenous (IV) Pantoprazole in Erosive Esophagitis
Phase 4
Completed
20 enrolled
Emory University
Wyeth is now a wholly owned subsidiary of Pfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to examine whether pantoprazole (Protonix) given through continuous intravenous infusion for 72 hours is superior to Protonix given through once a day IV injection in the treatment of erosive esophagitis.
Timeline
- Start
- 2004-07
- Primary completion
- 2006-07
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pantoprazole | Other / unclassified | — | Intravenous |